Nucleate x Carta: State of Biotech Markets

​Join us for an exclusive event, co-hosted by Nucleate and Carta, that delves into the current state of the biotech market and trends in fundraising for 2024. This event kicks off with a 15-minute market overview, drawing insights from the latest Carta x Nucleate report on biotech funding and market dynamics and presented by Peter Walker (Head of Insights, Carta). Learn about the key factors shaping the landscape for early-stage biotech ventures, including equity splits, pre-seed to Series A fundraising patterns, dilution trends, and exit strategies.

​Following the overview, Eric Dai (Investor, Dimension) & Becky Pferdehirt (Investment Partner, a16z) will join a moderated discussion with Peter to share their perspectives on navigating today’s fundraising climate. The panel will explore emerging strategies for securing capital, the evolving role of investors, and how startups can position themselves for success.

​Don’t miss the chance to engage with this dynamic panel and ask your most pressing questions during the Q&A session.

​Agenda:

• ​15-minute market overview: Key insights from the Carta x Nucleate report

• ​Panel discussion: Fundraising strategies featuring biotech investors

• ​Q&A session: Open floor for audience questions

​Whether you're a biotech entrepreneur, investor, or industry professional, this event is designed to provide actionable insights and foster meaningful connections!